| 2025-12-03 |
详情>>
股本变动：
变动后总股本3540.82万股
|
| 2025-12-03 |
详情>>
业绩披露：
2026年中报每股收益-0.57美元,归母净利润-2020万美元,同比去年增长-1.51%
|
| 2025-09-09 |
详情>>
业绩披露：
2026年一季报每股收益-0.29美元,归母净利润-1030万美元,同比去年增长43.72%
|
| 2025-08-01 |
股东大会：
将于2025-09-17召开股东大会
会议内容 ▼▲
- 1.To elect seven director nominees to hold office until the Company’s 2026 Annual Meeting of Stockholders or until such director’s earlier resignation, or a respective successor is duly elected and appointed;
2.To ratify the Audit Committee’s selection of Ernst & Young LLP to serve as our independent registered public accounting firm for the fiscal year ending May 2, 2026;
3.To approve, on a non-binding, advisory basis, the compensation of Methode’s named executive officers;
4.To transact such other business as may properly come before the Annual Meeting or any adjournment or postponement thereof.
|
| 2025-07-09 |
详情>>
业绩披露：
2025年年报每股收益-1.77美元,归母净利润-6260万美元,同比去年增长49.23%
|
| 2025-07-09 |
详情>>
业绩披露：
2023年年报每股收益2.14美元,归母净利润7710.00万美元,同比去年增长-24.56%
|
| 2025-03-05 |
详情>>
业绩披露：
2025年三季报(累计)每股收益-0.97美元,归母净利润-3430万美元,同比去年增长48.03%
|
| 2025-03-05 |
财报披露：
美东时间 2025-03-05 盘后发布财报
|
| 2024-12-05 |
详情>>
业绩披露：
2025年中报每股收益-0.56美元,归母净利润-1990万美元,同比去年增长63.42%
|
| 2024-09-05 |
详情>>
业绩披露：
2025年一季报每股收益-0.52美元,归母净利润-1830万美元,同比去年增长-2133.33%
|
| 2024-09-05 |
详情>>
业绩披露：
2024年一季报每股收益0.03美元,归母净利润90.00万美元,同比去年增长-95.81%
|
| 2024-07-29 |
股东大会：
将于2024-09-11召开股东大会
会议内容 ▼▲
- 1.To elect each director nominee to hold office until the Company’s 2025 Annual Meeting of Stockholders or until such director’s earlier resignation, or a respective successor is duly elected and appointed;
2.To ratify the Audit Committee’s selection of Ernst & Young LLP to serve as our independent registered public accounting firm for the fiscal year ending May 3, 2025;
3.To approve, on a non-binding, advisory basis, the compensation of Methode’s named executive officers;
4.To transact such other business as may properly come before the Annual Meeting or any adjournment or postponement thereof.
|
| 2024-07-11 |
详情>>
业绩披露：
2024年年报每股收益-3.48美元,归母净利润-1.23亿美元,同比去年增长-259.92%
|
| 2024-03-07 |
详情>>
业绩披露：
2024年三季报(累计)每股收益-1.86美元,归母净利润-6600万美元,同比去年增长-195.65%
|
| 2023-12-07 |
详情>>
业绩披露：
2024年中报每股收益-1.52美元,归母净利润-5440万美元,同比去年增长-210.79%
|
| 2023-07-27 |
股东大会：
将于2023-09-13召开股东大会
会议内容 ▼▲
- 1.To elect each director nominee to hold office until the Company’s 2024 Annual Meeting of Stockholders or until such director’s earlier resignation, or a respective successor is duly elected and appointed;
2.To ratify the Audit Committee’s selection of Ernst & Young LLP to serve as our independent registered public accounting firm for the fiscal year ending April 27, 2024;
3.To approve, on a non-binding, advisory basis, the compensation of Methode’s named executive officers;
4.To hold an advisory vote on the frequency of advisory votes on the compensation of Methode’s named executive officers;
5.To transact such other business as may properly come before the Annual Meeting or any adjournment or postponement thereof.
|
| 2022-07-26 |
股东大会：
将于2022-09-14召开股东大会
会议内容 ▼▲
- 1.To elect each director nominee to hold office until the Company’s 2023 Annual Meeting of Stockholders or until such director’s earlier resignation, or a respective successor is duly elected and appointed;
2.To approve the Methode Electronics, Inc. 2022 Omnibus Incentive Plan;
3.To ratify the Audit Committee’s selection of Ernst & Young LLP to serve as our independent registered public accounting firm for the fiscal year ending April 29, 2023;
4.To approve, on a non-binding, advisory basis, the compensation of Methode’s named executive officers;
5.To transact such other business as may properly come before the Annual Meeting or any adjournment or postponement thereof.
|
| 2021-09-06 |
温馨提示：
美股因劳工节，9月6日休市一天
|
| 2021-07-27 |
股东大会：
将于2021-09-15召开股东大会
会议内容 ▼▲
- 1.To elect each director nominee to hold office until the Company’s 2022 Annual Meeting of Stockholders or until such director’s earlier resignation, or a respective successor is duly elected and appointed;
2.To ratify the Audit Committee’s selection of Ernst & Young LLP to serve as our independent registered public accounting firm for the fiscal year ending April 30, 2022;
3.To approve, on a non-binding, advisory basis, the compensation of Methode’s named executive officers;
4.To transact such other business as may properly come before the Annual Meeting or any adjournment or postponement thereof.
|
| 2020-07-28 |
股东大会：
将于2020-09-16召开股东大会
会议内容 ▼▲
- 1.To elect a Board of Directors;
2.To ratify the Audit Committee’s selection of Ernst & Young LLP to serve as our independent registered public accounting firm for the fiscal year ending May 1, 2021;
3.To provide advisory approval of Methode’s named executive officer compensation;
4.To transact such other business as may properly come before the Annual Meeting or any adjournment or postponement thereof.
|
| 2019-07-26 |
股东大会：
将于2019-09-13召开股东大会
会议内容 ▼▲
- 1.To elect a Board of Directors;
2.To ratify the Audit Committee’s selection of Ernst & Young LLP to serve as our independent registered public accounting firm for the fiscal year ending May 2, 2020;
3.To provide advisory approval of Methode’s named executive officer compensation;
4.To transact such other business as may properly come before the annual meeting or any adjournment or postponement thereof.
|
| 2018-07-30 |
股东大会：
将于2018-09-13召开股东大会
会议内容 ▼▲
- 1.To elect a Board of Directors;
2.To ratify the Audit Committee’s selection of Ernst & Young LLP to serve as our independent registered public accounting firm for the fiscal year ending April 27, 2019;
3.To provide advisory approval of Methode’s named executive officer compensation;
4.To transact such other business as may properly come before the annual meeting or any adjournment or postponement thereof.
|
| 2017-08-01 |
股东大会：
将于2017-09-14召开股东大会
会议内容 ▼▲
- 1. To elect a Board of Directors;
2. To ratify the Audit Committee’s selection of Ernst & Young LLP to serve as our independent registered public accounting firm for the fiscal year ending April 28, 2018;
3. To provide advisory approval of Methode’s named executive officer compensation;
4. To cast an advisory vote on the frequency of future advisory votes on Methode’s named executive officer compensation;
5. To transact such other business as may properly come before the annual meeting or any adjournment or postponement thereof.
|
| 2016-07-27 |
股东大会：
将于2016-09-15召开股东大会
会议内容 ▼▲
- 1.To elect a Board of Directors;
2.To ratify the Audit Committee’s selection of Ernst & Young LLP to serve as our independent registered public accounting firm for the fiscal year ending April 29, 2017;
3.To provide advisory approval of Methode’s named executive officer compensation;
4.To transact such other business as may properly come before the annual meeting or any adjournment or postponement thereof.
|